Schizophr Bull. 2007 Sep;33(5):1120-30. Epub 2007 Jul 19.

Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA.

Source

rwbuchanan@mprc.umaryland.edu

Abstract

Wayne Fenton was a major driving force behind the establishment of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) and Treatment Units for Research on Neurocognition and Schizophrenia (TURNS) project mechanisms. These projects were designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia. The MATRICS project identified 3 drug mechanisms of particular interest: cholinergic, dopaminergic, and glutamatergic. The TURNS project is designed to select potential cognitive-enhancing agents and evaluate their potential efficacy in the context of proof of concept or clinical efficacy trials. This article reviews the rationale for these 3 approaches and provides an update on the development of therapeutic agents, which act through one of these 3 mechanisms.

PMID:: 17641146; [PubMed - indexed for MEDLINE]
PMCID:: PMC2632365

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Schizophrenia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review The neurobiology of cognition in schizophrenia. [J Clin Psychiatry. 2006]
Review The neurobiology of cognition in schizophrenia.
Tamminga CA. J Clin Psychiatry. 2006; 67 Suppl 9:9-13; discussion 36-42.
Review The neurobiology of cognition in schizophrenia. [J Clin Psychiatry. 2006]
Review The neurobiology of cognition in schizophrenia.
Tamminga CA. J Clin Psychiatry. 2006 Sep; 67(9):e11.
Review Molecular targets for treating cognitive dysfunction in schizophrenia. [Schizophr Bull. 2007]
Review Molecular targets for treating cognitive dysfunction in schizophrenia.
Gray JA, Roth BL. Schizophr Bull. 2007 Sep; 33(5):1100-19. Epub 2007 Jul 7.
New paradigms for treatment development. [Schizophr Bull. 2007]
New paradigms for treatment development.
Stover EL, Brady L, Marder SR. Schizophr Bull. 2007 Sep; 33(5):1093-9. Epub 2007 Aug 2.
Review The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. [Am J Psychiatry. 2001]
Review The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
Goff DC, Coyle JT. Am J Psychiatry. 2001 Sep; 158(9):1367-77.

See reviews... See all...

Cited by 9 PubMed Central articles

Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. [PLoS One. 2011]
Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia.
Yoshida T, Suga M, Arima K, Muranaka Y, Tanaka T, Eguchi S, Lin C, Yoshida S, Ishikawa M, Higuchi Y, et al. PLoS One. 2011; 6(5):e20469. Epub 2011 May 26.
Newer molecules in the treatment of schizophrenia: A clinical update. [Indian J Pharmacol. 2011]
Newer molecules in the treatment of schizophrenia: A clinical update.
Ghosh A, Chakraborty K, Mattoo SK. Indian J Pharmacol. 2011 Apr; 43(2):105-12.
A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression. [Neurosci Res. 2011]
A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression.
Ozeki Y, Pickard BS, Kano S, Malloy MP, Zeledon M, Sun DQ, Fujii K, Wakui K, Shirayama Y, Fukushima Y, et al. Neurosci Res. 2011 Feb; 69(2):154-60. Epub 2010 Oct 16.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Recent advances in the development of novel pharmacological agents for the treat...
Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.
Schizophr Bull. 2007 Sep ;33(5):1120-30. Epub 2007 Jul 19 .

PubMed
Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after...
Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells.
J Immunol. 2007 Aug 1 ;179(3):1988-95.

PubMed
Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblG...
Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo.
J Immunol. 2007 Aug 1 ;179(3):1693-9.

PubMed
TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cel...
TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.
J Immunol. 2007 Aug 1 ;179(3):1449-57.

PubMed
Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth fac...
Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
Endocrinology. 2007 Oct ;148(10):4906-17. Epub 2007 Jul 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 9 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information